Thursday, 4 November 2021

Protagonist Therapeutics Announces Updated Data from Phase 2 Study of Rusfertide in Polycythemia Vera Selected for Oral Presentations at the ASH 2021 Annual Meeting - Yahoo Finance

Protagonist Therapeutics Announces Updated Data from Phase 2 Study of Rusfertide in Polycythemia Vera Selected for Oral Presentations at the ASH 2021 Annual Meeting  Yahoo Finance

from "phlebotomist" - Google News https://yhoo.it/3bJe38x

No comments:

Post a Comment